As Navigantis operates in stealth mode, little is known about the Miami-based startup’s telesurgical system.
Navigantis says it has what it takes to win the race to treat stroke patients remotely with its interventional robotic platform VASCO, which is already being used in a clinical trial for neurointerventional procedures.
Stroke telesurgery is one of the biggest opportunities in medtech. Major OEMs and startups barely out of stealth mode are racing to expand access to life-saving care with remote robotics.
To better predict who gets there first, we’ve been reaching out to device developers to ask why they think they can win. Some have already demonstrated their technology, while others are keeping details close to their chest.
As the Navigantis operates in stealth mode, not much is known about the Miami-based startup’s telesurgical system, but the company closed a $12 million Series A round in 2024.
Publicly, the company said it has “developed an interventional robotic platform [VASCO] for a wide range of neurovascular procedures and indications, including acute ischemic stroke.” While details about VASCO remain secret, Navigantis is clinically evaluating the investigational device outside of the U.S.
The 2026 MDO Medtech Startups Special Report: Technical tips and actionable advice for device startups
In December 2024, Navigantis said VASCO was used in neurovascular clinical procedures as part of a clinical trial in South Korea. The trial includes patients undergoing diagnostic cerebral angiogram, brain tumor embolization and mechanical thromectomy for ischemic stroke, the company said.
“This achievement marks an important milestone in our mission to introduce the advantages of robotic procedures to the interventional neurovascular field,” Navigantis CEO Mor Dayan said in a 2024 news release. “The VASCO robotic platform has the potential to redefine how we approach the most complex and time-sensitive neurovascular procedures, ultimately improving both patient outcomes and procedural efficiencies. This is one of the first steps towards enabling robotic telesurgery for stroke patients, which could dramatically reduce response times and enhance access to timely critical care.”
The ongoing study aims to “assess whether the VASCO robotic system navigates catheter or other procedural devices successfully to the target vessel,” according to the clinical trial’s website. The study is estimated to be completed at the end of 2026, according to the study details.
With system assessments underway, we asked Dayan why his company has what it takes to win the telesurgical robotic stroke technology race. The following has been lightly edited for length and clarity.
“At Navigantis, we believe neurovascular robotics can democratize access to expertise across neurovascular procedures. Our VASCO Robotic Platform is designed to address the core barriers behind this massive unmet need.
“Navigantis’ VASCO technology is designed to improve precision, expand access to specialist care, and ultimately enable a safer, more scalable approach to complex endovascular procedures. With the VASCO remote console, an interventionalist can extend their hands into an angio suite hundreds of miles away and perform the full procedure from start to finish. The platform is built with a focus on ease of use, seamless integration into the existing standard of care, assistive automation algorithms, and appropriate clinical guardrails.
“What sets Navigantis apart is not only the strength of the VASCO platform, but also the company’s integrated approach: combining deep clinical, product, robotics, and software expertise with disciplined execution and a clear path toward real-world clinical impact. This is reinforced by a leadership team with decades of hands-on experience combined, developing novel robotics and neuro technologies, as well as an experienced board of directors and medtech investor base that bring strategic, medical technology, operational and commercialization expertise to guide the company’s growth.”
Read our July 2026 surgical robotics issue of MDO magazine for more about the stroke telesurgery race and keep up on the latest developments by subscribing to our newsletter. You can also read more about innovative surgical robotics companies in our latest special report.
